SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 84 filers reported holding SERES THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 2.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,169,000 | +14.3% | 340,890 | +177.1% | 0.00% | 0.0% |
| Q4 2021 | $1,023,000 | -36.6% | 123,005 | -47.0% | 0.00% | -71.4% |
| Q3 2021 | $1,614,000 | +520.8% | 231,950 | +257.7% | 0.01% | +250.0% |
| Q3 2019 | $260,000 | -81.9% | 64,843 | -85.5% | 0.00% | -83.3% |
| Q2 2019 | $1,439,000 | -14.5% | 446,700 | +82.2% | 0.01% | +50.0% |
| Q1 2019 | $1,684,000 | – | 245,180 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |